Access MeMed BV®
Accurately aids in distinguishing between bacterial and viral infections
Since bacterial and viral infections are clinically indistinguishable, physicians are often challenged to decide whether to treat or not with antibiotics.
By providing host response information, we help physicians make more informed decisions about how and when to treat.
Using serum or plasma, Access MeMed BV computationally integrates the levels of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely viral immune response with an overall diagnostic accuracy of 95% and a negative predictive value for bacterial infections of 98.8%.
The Access MeMed BV assay is now available on Beckman Coulter’s DxI 9000 and Access 2 immunoassay analyzers allowing you to leverage your existing lab infrastructure to empower timely, evidence-based decision making.
From emerging threats to diagnostic breakthroughs: A strategic look ahead in AMR – Rebroadcast from ESCMID Global 2026 with live Q&A
Wednesday, May 27 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
This SelectScience® webinar features a rebroadcast from ESCMID Global 2026, followed by a live Q&A session. Brought to you by Danaher companies, Beckman Coulter Diagnostics and Cepheid, this session will explore the role of emerging diagnostic modalities to combat the development and spread of antimicrobial resistance (AMR).
The session will apply lessons learned from MRSA and VRE testing to emerging AMR threats such as CRE and C. auris. There will be an exploration of AMR gene detection using molecular methods such as syndromic PCR panels and NGS. Besides molecular methods, we will explore emerging rapid phenotypic antimicrobial susceptibility tests (AST) and bacterial versus viral host response-based diagnostics and their potential to improve antimicrobial stewardship and patient outcomes.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 90 minutes
- Format: Rebroadcast of recorded symposium from ESCMID Global 2026 with live Q&A
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.





